Request Free Sample
×
Sodium Glucose Cotransporter 2 Inhibitor Market
ID: MRFR/HC/37501-HCR
100 Pages
October 2025
Rapport d’étude de marché sur les inhibiteurs du cotransporteur de glucose sodique 2 (SGLT2) par type de médicament (Dapagliflozine, Canagliflozine, Empagliflozine, Ertugliflozine), par voie d’administration (orale, intraveineuse), par application (diabète de type 2, insuffisance cardiaque, maladie rénale chronique), par canal de distribution (pharmacies hospitalières, pharmacies de détail, pharmacies en ligne) et par région (Amérique du Nord, Europe, Amérique du Sud, Asie) Pacifique, Moyen-Orient et Afrique) - Prévisions jusqu'en 2034
Les principales entreprises du marché Sodium Glucose Cotransporter 2 Inhibitor Market incluent
Portée du rapport
FAQs
What is the current valuation of the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor Market?
The market valuation was 10.02 USD Billion in 2024.
What is the projected market size for the SGLT2 Inhibitor Market by 2035?
The market is expected to reach 33.89 USD Billion by 2035.
What is the expected CAGR for the SGLT2 Inhibitor Market during the forecast period?
The expected CAGR for the market from 2025 to 2035 is 11.71%.
Which drug types are leading in the SGLT2 Inhibitor Market?
Dapagliflozin, Canagliflozin, Empagliflozin, and Ertugliflozin are the leading drug types.
What are the projected revenues for Dapagliflozin by 2035?
Dapagliflozin is projected to generate revenues of 10.0 USD Billion by 2035.
How does the route of administration impact the SGLT2 Inhibitor Market?
The oral route is expected to generate 20.0 USD Billion, while intravenous administration is projected at 13.89 USD Billion by 2035.
What applications are driving growth in the SGLT2 Inhibitor Market?
Type 2 Diabetes, Heart Failure, and Chronic Kidney Disease are key applications driving market growth.
What is the revenue projection for Type 2 Diabetes applications by 2035?
The revenue for Type 2 Diabetes applications is projected to reach 13.0 USD Billion by 2035.
Which distribution channels are most significant in the SGLT2 Inhibitor Market?
Hospital pharmacies, retail pharmacies, and online pharmacies are significant distribution channels.
What are the projected revenues for retail pharmacies in the SGLT2 Inhibitor Market by 2035?
Retail pharmacies are expected to generate revenues of 13.0 USD Billion by 2035.
Télécharger l'échantillon gratuit
Veuillez remplir le formulaire ci-dessous pour recevoir un échantillon gratuit de ce rapport
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah Malgeri
Co-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph Aguayo
Sales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkamp
Account and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria Dodd
Program Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan Choi
Senior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Mark Irwin
Management Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif Moroglu
Strategy & Business Development Director
Étude de cas
Aerospace & Defense
Laisser un commentaire